JB Chemicals & Pharmaceuticals

L24390MH1976PLC019380 · ISIN — · 3 filings, FY 2022-23 to FY 2024-25 · standalone basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

reporting_boundary_changed. Reporting boundary changed across years: FY 2022-23 Standalone, FY 2023-24 Standalone basis, FY 2024-25 Standalone. Year-on-year figures cover different entities.

CategoryFY 2022-23FY 2023-24FY 2024-25
Plastics including packaging not filednot filed0
E-waste not filednot filed1.99
Hazardous waste not filednot filed355.81
Other waste not filednot filednot filed
Total reclaimed 00357.8

Recycled or reused input material

Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.

Input material, as filedFY 2022-23FY 2023-24FY 2024-25
NA 0.0%not filednot filed

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
2100 Oral Solids (tabs + capsules) 56.00%
2100 Injectables 22.00%
2100 Liquids 9.00%
2100 Lozenges 5.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Standalone 2023-06-30 28,84,16,00,000
FY 2023-24 Standalone basis 2024-04-30 32,98,64,36,433
FY 2024-25 Standalone 2025-05-31 36,72,34,36,858.17

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error